Summary

The United States has been at the forefront of ventilator innovation and development. Various American companies and research institutions have contributed to advancing the technology, making ventilators more efficient and adaptable to different medical situations. The COVID-19 pandemic highlighted the importance of ventilators in treating severe respiratory cases. In 2020, there was a surge in demand for ventilators globally, and the USA played a crucial role in ramping up production to meet the increased need. The response to the ventilator shortage during the COVID-19 pandemic involved collaborations between the U.S. government, private companies, and non-profit organizations. Initiatives such as the Defence Production Act were utilised to mobilise resources and accelerate ventilator production. Ventilators in the USA are designed to be adaptable for use in various healthcare settings, including hospitals, emergency rooms, and even field hospitals. This adaptability has been crucial, especially during times of crisis or natural disasters. Since the spring, almost 200,000 critical care ventilators have been produced in the United States by medical device manufacturers, of which 155,000 are destined for the Strategic National Stockpile, a dramatic increase in the nation's ventilator capacity. Simultaneously, medical professionals have discovered alternative methods of providing oxygen to patients who are having difficulty breathing during COVID 19. Globally as well as in the United States, there were coordinated attempts to boost ventilator manufacturing in response to this spike in demand. In order to increase production, the U.S. government and commercial businesses called for emergency measures and worked with ventilator manufacturers. In order to fulfil the pressing need for ventilators, there were also measures to reuse already-existing production facilities, seek the assistance of other sectors, and enable collaborations.

According to the research report "United States Ventilator Market Overview, 2028," published by Bonafide Research, the United States Ventilator market was valued at more than USD 2 Billion in 2022. A poor diet, obesity, and a lack of physical exercise are among the main risk factors that increase the prevalence of respiratory illnesses. The occurrence or severity of diseases including asthma, COPD, exertional dyspnea, pulmonary embolism, aspiration pneumonia, and obesity-hypoventilation syndrome has been linked to weight gain. According to a Better Policies for a Healthier America report, the obesity prevalence among adult Americans is still rising, accounting for four out of ten cases. Because obesity is linked to a number of illnesses, including type 2 diabetes, heart disease, stroke, arthritis, sleep apnea, and some malignancies, it is imperative that the condition be addressed. Obesity is predicted to raise US healthcare spending by more than USD 160 billion a year, including billions from Medicare and Medicaid, according to the Medical Expenditure Panel Survey (MEPS). If extra expenses from overweight (more than $500 per person) are taken into account, this number increases to approximately $195 billion, underscoring the significant economic burden of overweight and obesity in the US. Advances in ventilator technology, including improved functionality, better user interfaces, and enhanced portability, can drive demand as healthcare providers seek to upgrade their equipment. Technological innovation can also lead to the development of more specialised and efficient ventilators. Ventilators are essential in critical care units for patients undergoing surgeries, trauma victims, and those with severe respiratory distress. As healthcare facilities expand and critical care capacities increase, there is a corresponding need for ventilators to support these critical care services.

Based on mobility, the market is segmented into Instruments/Ventilator Machines and Portable/Transportable Ventilators. Among them, in the United States, Instruments/Ventilator Machines leads the market. The United States has a history of innovation in medical technology, including ventilator development. Many pioneering advancements in medical devices, including ventilators, have originated from research institutions and companies in the U.S. U.S. companies often allocate significant resources to research and development, leading to continuous advancements in ventilator technology. Investment in innovation allows these companies to produce state-of-the-art devices that meet evolving healthcare needs. During times of crisis, such as the COVID-19 pandemic, the U.S. government has played a role in supporting the production and distribution of ventilators. This collaboration between the public and private sectors has further strengthened the position of U.S. companies in the global market. According to the report, the end users are segmented into hospitals, ambulatory surgical centres, home healthcare, and others; among them, home healthcare is significantly contributing to the market share. There is a broader trend in healthcare to shift certain types of care from traditional hospital settings to home-based environments. This shift is driven by factors such as cost-effectiveness, patient preference, and advancements in remote monitoring technologies. For individuals with chronic respiratory conditions, receiving ventilator support at home can lead to improved quality of life and better overall outcomes. Home-based care allows patients to maintain a level of independence and reduces the need for prolonged hospital stays. The ageing population in the USA is more likely to experience chronic health conditions, including respiratory issues. Ventilators in home healthcare settings become a viable option for managing these chronic conditions while providing a higher level of comfort and convenience for elderly individuals.

In terms of the indication types, they include cardiovascular disorders and hypertension, cancer, respiratory diseases, diabetes, movement disorders, wound care, pregnancy, hearing disorders, and other indications. Among them in the USA, other indications like sleep disorders and kidney disorders are growing at the highest rate. In some cases, individuals with complex sleep-related breathing disorders require ventilatory assistance during sleep. Ventilators are used in specialised sleep centres or home settings under the guidance of healthcare professionals. Advanced stages of CKD can lead to respiratory complications, including respiratory muscle weakness and difficulty breathing. In such cases, ventilators be used to provide respiratory support. Additionally, patients with CKD undergo procedures or surgeries that require post-operative ventilatory support. Furthermore, kidney disorders can result in fluid retention and pulmonary oedema, leading to respiratory distress. Ventilators are used in critical care settings to manage respiratory compromise in these cases.

Considered in this report:
• Geography: United States
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• United States Ventilator market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Mobility
• Instruments/ Ventilator Machines
• Portable/transportable Ventilators

By End User
• Hospitals
• Ambulatory Surgical Centers
• Home Healthcare
• Others

By Indication
• Cardiovascular Disorders & Hypertension
• Cancer
• Respiratory Diseases
• Diabetes
• Movement Disorders
• Wound Care
• Pregnancy
• Hearing Disorders
• Other Indications

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Ventilator industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents